Monthly News Roundup - December 2016
Biogen ’s Spinraza Approved for Spinal Muscular Atrophy
The U.S. Food and Drug Administration (FDA) has cleared Biogen ' s Spinraza (nusinersen), the first drug for spinal muscular atrophy (SMA), a rare and often fatal genetic disease affecting...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news
More News: Food and Drug Administration (FDA) | Genetics | Pharmaceuticals | Spinal Muscular Atrophy